February 22, 2018
Rose
Palo Alto, California-based Cognoa’s machine learning app for pediatric behavioral health has received categorization from the FDA as a Class 2 diagnostic medical device for autism, according to an announcement from the company.
from MobiHealthNews http://ift.tt/2HBimlN
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment